Diminished efficacy of PD-(L)1 inhibition in STK11- and KEAP1-mutant lung adenocarcinoma is impacted by KRAS mutation status Meeting Abstract
| Authors: | Ricciuti, B.; Arbour, K.; Lin, J.; Vajdi, A.; Tolstorukov, M.; Hong, L.; Zhang, J.; Vokes, N.; Li, Y.; Spurr, L.; Cherniack, A.; Recondo, G.; Lamberti, G.; Rizvi, H.; Egger, J.; Plodkowski, A.; Khosrowjerdi, S.; Digumarthy, S.; Vaz, N.; Park, H.; Nishino, M.; Sholl, L.; Barbie, D.; Altan, M.; Heymach, J.; Skoulidis, F.; Gainor, J.; Hellmann, M.; Awad, M. |
| Abstract Title: | Diminished efficacy of PD-(L)1 inhibition in STK11- and KEAP1-mutant lung adenocarcinoma is impacted by KRAS mutation status |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | pd-(l)1 blockade; kras/keap1; kras/stk11 |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S341 |
| Language: | English |
| ACCESSION: | WOS:000631349600513 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.532 |
| Notes: | Meeting Abstract: P14.26 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
411Hellmann -
114Plodkowski -
88Arbour -
122Rizvi -
68Egger
Related MSK Work